These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16625647

  • 1. Vaccines for preventing malaria (SPf66).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005966. PubMed ID: 16625647
    [Abstract] [Full Text] [Related]

  • 2. WITHDRAWN: Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2007 Jul 18; 2003(4):CD000129. PubMed ID: 17636596
    [Abstract] [Full Text] [Related]

  • 3. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003 Jul 18; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2000 Jul 18; (2):CD000129. PubMed ID: 10796492
    [Abstract] [Full Text] [Related]

  • 5. Vaccines for preventing malaria (blood-stage).
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2006 Oct 18; 2006(4):CD006199. PubMed ID: 17054281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 8. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U, Leach A, Drakeley CJ, Bennett S, Olaleye BO, Fegan GW, Jawara M, Langerock P, George MO, Targett GA.
    Lancet; 1995 Aug 19; 346(8973):462-7. PubMed ID: 7637479
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
    Acosta CJ, Galindo CM, Schellenberg D, Aponte JJ, Kahigwa E, Urassa H, Schellenberg JR, Masanja H, Hayes R, Kitua AY, Lwilla F, Mshinda H, Menendez C, Tanner M, Alonso PL.
    Trop Med Int Health; 1999 May 19; 4(5):368-76. PubMed ID: 10402973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The development of malaria vaccines: SPf66--what next?
    Tanner M, Alonso PL.
    Schweiz Med Wochenschr; 1996 Jul 09; 126(27-28):1210-5. PubMed ID: 8766632
    [Abstract] [Full Text] [Related]

  • 12. Azithromycin for treating uncomplicated malaria.
    van Eijk AM, Terlouw DJ.
    Cochrane Database Syst Rev; 2011 Feb 16; 2011(2):CD006688. PubMed ID: 21328286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG.
    Lancet; 1996 Sep 14; 348(9029):701-7. PubMed ID: 8806288
    [Abstract] [Full Text] [Related]

  • 15. An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.
    Bojang KA, Obaro SK, D'Alessandro U, Bennett S, Langerock P, Targett GA, Greenwood BM.
    Vaccine; 1998 Jan 14; 16(1):62-7. PubMed ID: 9607010
    [Abstract] [Full Text] [Related]

  • 16. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
    Alonso PL, Smith TA, Armstrong-Schellenberg JR, Kitua AY, Masanja H, Hayes R, Hurt N, Font F, Menendez C, Kilama WL, Tanner M.
    J Infect Dis; 1996 Aug 14; 174(2):367-72. PubMed ID: 8699068
    [Abstract] [Full Text] [Related]

  • 17. Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.
    Bojang KA, Obaro SK, Leach A, D'Alessandro U, Bennett S, Metzger W, Ballou WR, Targett GA, Greenwood BM.
    Parasite Immunol; 1997 Dec 14; 19(12):579-81. PubMed ID: 9458470
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M, Prata A, Struchiner CJ, Tosta CE, Tauil P, Boulos M.
    Am J Trop Med Hyg; 1998 Mar 14; 58(3):378-85. PubMed ID: 9546423
    [Abstract] [Full Text] [Related]

  • 19. The vaccine is dead--long live the vaccine.
    Snounou G, Rénia L.
    Trends Parasitol; 2007 Apr 14; 23(4):129-32. PubMed ID: 17300988
    [Abstract] [Full Text] [Related]

  • 20. Indoor residual spraying for preventing malaria.
    Pluess B, Tanser FC, Lengeler C, Sharp BL.
    Cochrane Database Syst Rev; 2010 Apr 14; 2010(4):CD006657. PubMed ID: 20393950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.